Portola Pharmaceuticals Inc., South San Francisco (United States of America)
0
follower
27
more
presentations
in this session
Major adverse cardiovascular events (MACE) are reduced in testosterone-treated vs. untreated hypogonadal men: real-life evidence from a controlled registry study